IDEVAX is an ISO13845 certified Belgian medical device company specializing in innovative drug delivery solutions for prophylactic and therapeutic usage. At the heart of the company is VAX-ID®, an award-winning patented device that simplifies intradermal administration. VAX-ID® ensures accurate, reliable, and user-independent skin drug delivery with a high ease of use and minimal training. The device is CE marked and has UK MHRA registration.
Our device is versatile and can be leveraged across various applications including cell and gene therapies, ATMPs, and immunotherapies such as cancer vaccines. VAX-ID® may offer benefits such as improving patient compliance, enhancing immune response, and improve therapy accessibility.
Join us at our stand to discover how IDEVAX's innovative solutions are shaping the future of advanced therapies and improve patient outcomes worldwide.